Cost-effectiveness of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus. [electronic resource]
Producer: 20051229Description: 191-200 p. digitalISSN:- 1413-8670
- Acetamides -- economics
- Anti-Bacterial Agents -- economics
- Cost-Benefit Analysis
- Cross Infection -- drug therapy
- Drug Costs
- Humans
- Linezolid
- Methicillin Resistance -- drug effects
- Oxazolidinones -- economics
- Pneumonia, Staphylococcal -- drug therapy
- Respiration, Artificial -- adverse effects
- Staphylococcus aureus -- drug effects
- Vancomycin -- economics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.